MFDS — authorised 6 March 2015
- Marketing authorisation holder: ASTELLAS
- Status: likely_approved
MFDS authorised Cresemba on 6 March 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 6 March 2015.
ASTELLAS holds the South Korean marketing authorisation.